Structure–activity relationship of neomycin, paromomycin, and neamine–arginine conjugates, targeting HIV-1 gp120–CXCR4 binding step
- 13 August 2003
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 60 (3) , 181-192
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- HIV-1 Envelope Is a Neutral Antagonist to CXCR4 in T-CellsBiochemical and Biophysical Research Communications, 2001
- Anti-Human Immunodeficiency Virus Activity of Novel Aminoglycoside-Arginine Conjugates at Early Stages of InfectionAIDS Research and Human Retroviruses, 2000
- Tackling tatJournal of Molecular Biology, 1999
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998
- CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5Nature, 1996
- CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5Nature, 1996
- The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1Nature, 1996
- The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entryNature, 1996
- Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1Nature, 1996
- STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORSAnnual Review of Biochemistry, 1994